49
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Matrix metalloproteinase (MMP) expression in experimental choroidal neovascularization

, , , , &
Pages 684-690 | Published online: 02 Jul 2009

Reference

  • Kvanta A, Algvere P, Berglin P, Seregard S. Subfoveal fibrovascular membranes in age-related macular degen-eration express vascular endothelial growth factor (VEGF). Invest Ophthalmol Vis Sci. 1996;37:1929–1934.
  • Amin R, Puklin JE, Frank RN. Growth factor localiza-tion in choroidal neovascular membranes of age-related macular degeneration. Invest Ophthalmol Vis Sci. 1994; 35:3178–3188.
  • Ishibashi T, Hata Y, Yoshikawwa H, Nakagawa K, Sueishi K, Inomata H. Expression of vascular endothe-lial growth factor in experimental choroidal neovasculari-zation. Graefe's Arch Clin Exp Ophthalmol. 1997;235: 159–167.
  • Shen WY, Yu MJ, Barry CJ, Constable IJ, Rakoczy PE. Expression of cell adhesion molecules and vascular endo-thelial growth factor in experimental choroidal neovas-cularization. Br J Ophthalmol. 1998;82:1063–1071.
  • Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, De-revjanik NL, Vinores SA, Basilico C, Campochiaro PA. Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol. 1998;153: 1641–1646.
  • Steen B, Sejersen S, Berglin L, Seregard S, Kvanta A. Matrix metalloproteinases and metalloproteinase inhibitors in choroidal neovascular membranes. Invest Ophthalmol Vis Sci. 1998;39:2194–2200.
  • Woessner JF. The family of matrix metalloproteinases. Ann NY Acad Sci. 1994;732:11–21.
  • Mignatti P, Rifkin DB. Plasminogen activators and matrixmetalloproteinases in angiogenesis. Enzyme Protein. 1996;49:117–137.
  • Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. Reduced angiogenesis and tumor progres-sion in gelatinase A-deficient mice. Cancer Res. 1998;58: 1048–1051.
  • Alexander JP, Samples JR, Acott TS. Growth factor and cytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression. Curr Eye Res. 1998;17:276–285.
  • Guggenheim JA, McBrein NA. Form-deprivation myopia induces activation of scleral matrix metalloproteinase-2 in tree shrew. Invest Ophthalmol Vis Sci. 1996;37:1380–1395.
  • Fini EM, Parks WC, Rinehart WB, Girard MT, Matsubara M, Cook JR, West-Mays JA, Sadow PM, Burgeson RE, Jeffrey JJ, Raizman MB, Kreuger RR, Zieske JD. Role of matrix metalloproteinases in failure to re-epithelial-ize after corneal injury. Am J Pathol. 1996;149:1287–1302 .
  • Das A, McGuire PG, Eriqat C, Ober RR, DeJuan Jr E, Williams GA, McLamore A, Biswas J, Johnson DW. Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. In-vest Ophthalmol Vis Sci. 1999;40:809–813.
  • Kadonosono K, Yazama F, Itoh N, Sawada H, Ohno S. Expression of matrix metalloproteinase-7 in choroidal neovascular membranes in age-related macular degen-eration. Am J Ophthalmol. 1999;128: 382–384.
  • Corcoran ML, Hewitt RE, Kleiner Jr DE, Stetler-Stevenson WG. MMP-2: expression, activation and in-hibition. Enzyme Protein. 1996;49: 7–19.
  • Kvanta A, Sarman S, Fagerholm P, Seregard S, Steen B. Expression of matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) in inflamma-tion-related corneal neovascularization. Exp Eye Res. 2000;70:419–428.
  • Das A, Puklin JE, Frank RN, Zhang NL. Ultrastructural immunocytochemistry of subretinal neovascular mem-branes in age-related macular degeneration. Ophthalmol-ogy. 1992;99:1368–1376.
  • Padgett LC, Lui GM, Werb Z, LaVail MM. Matrix metalloproteinase-2 and tissue inhibitor of metallopro-teinase-1 in retinal pigment epithelium and interphoto-receptor matrix: vectorial secretion and regulation. Exp Eye Res. 1997;64:927–938.
  • Smine A, Plantner JJ. Membrane type-1 matrix metallo-proteinase in human ocular tissues. Curr Eye Res. 1997; 16:925–929.
  • Shaifee A, Tezel TH, Ferguson TA, Kaplan HJ. Efficacy of modulators of angiogenesis on subretinal neovasculari-zation in vivo. Invest Ophthalmol Vis Sci. 2000; 4435.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.